Salivary gland and nasopharyngeal cancers in individuals with acquired immunodeficiency syndrome in United States
Corresponding Author
Fatma M. Shebl
Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Rockville, MD
Fax: +301-402-0817
Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd., EPS 7074, Rockville, MD 20852, USASearch for more papers by this authorKishor Bhatia
Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Rockville, MD
Search for more papers by this authorEric A. Engels
Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Rockville, MD
Search for more papers by this authorCorresponding Author
Fatma M. Shebl
Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Rockville, MD
Fax: +301-402-0817
Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd., EPS 7074, Rockville, MD 20852, USASearch for more papers by this authorKishor Bhatia
Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Rockville, MD
Search for more papers by this authorEric A. Engels
Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Rockville, MD
Search for more papers by this authorAbstract
Individuals with acquired immunodeficiency syndrome (AIDS) manifest an increased risk of cancer, particularly cancers caused by oncogenic viruses. Because some salivary gland and nasopharyngeal cancers are associated with Epstein Barr virus, the impact of AIDS on these cancers needs further evaluation. We used linked U.S. AIDS and cancer registry data (N = 519,934 people with AIDS) to derive standardized incidence ratios (SIRs) comparing risk of salivary gland and nasopharyngeal cancers to the general population. For salivary gland cancers (N = 43 cases), individuals with AIDS had strongly elevated risks for lymphoepithelial carcinoma (SIR 39, 95% CI 16–81) and squamous cell carcinoma (SIR 4.9, 95% CI 2.5–8.6). Among nasopharyngeal cancers (N = 39 cases), risks were elevated for both keratinizing and nonkeratinizing carcinomas (SIR 2.4, 95% CI 1.5–3.7 and SIR 2.4, 95% CI 1.2–4.4, respectively). The elevated risks of salivary gland and nasopharyngeal cancers among people with AIDS suggest that immunosuppression and oncogenic viral infections are etiologically important.
References
- 1 Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007; 370: 59–67.
- 2 IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Epstein-Barr virus and Kaposi's Sarcoma herpesvirus/human herpesvirus 8. IARC monograph on the evaluation of carcinogenic risks to humans / WHO Lyon, France 1997;70:47-373.
- 3 Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000; 92: 1500–10.
- 4 D'Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 2009; 199: 1263–9.
- 5 Pauk J, Huang ML, Brodie SJ, Wald A, Koelle DM, Schacker T, Celum C, Selke S, Corey L. Mucosal shedding of human herpesvirus 8 in men. N Engl J Med 2000; 343: 1369–77.
- 6 Ammatuna P, Campisi G, Giovannelli L, Giambelluca D, Alaimo C, Mancuso S, Margiotta V. Presence of Epstein-Barr virus, cytomegalovirus and human papillomavirus in normal oral mucosa of HIV-infected and renal transplant patients. Oral Dis 2001; 7: 34–40.
- 7 Niedobitek G. Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma. Mol Pathol 2000; 53: 248–54.
- 8 Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol 2002; 12: 431–41.
- 9 Kim KI, Kim YS, Kim HK, Chae YS, Yoem BW, Kim I. The detection of Epstein-Barr virus in the lesions of salivary glands. Pathol Res Pract 1999; 195: 407–12.
- 10 Tsai CC, Chen CL, Hsu HC. Expression of Epstein-Barr virus in carcinomas of major salivary glands: a strong association with lymphoepithelioma-like carcinoma. Hum Pathol 1996; 27: 258–62.
- 11 Friborg JT, Melbye M. Cancer patterns in Inuit populations. Lancet Oncol 2008; 9: 892–900.
- 12 Friborg J, Koch A, Wohlfarht J, Storm HH, Melbye M. Cancer in Greenlandic Inuit 1973–1997: a cohort study. Int J Cancer 2003; 107: 1017–22.
- 13 Lanier AP, Alberts SR. Cancers of the buccal cavity and pharynx in circumpolar Inuit. Acta Oncol 1996; 35: 545–52.
- 14 Parkin D, Whelan S, Ferlay J, Teppo L, Thomas D. Cancer incidence in five continents, vol. 8. Lyon: IARC Press, 2003.
- 15 Albeck H, Nielsen NH, Hansen HE, Bentzen J, Ockelmann HH, Bretlau P, Hansen HS. Epidemiology of nasopharyngeal and salivary gland carcinoma in Greenland. Arctic Med Res 1992; 51: 189–95.
- 16 O'Sullivan EM. International variation in the incidence of oral and pharyngeal cancer. Community Dent Health 2008; 25: 148–53.
- 17 Borg MF, Benjamin CS, Morton RP, Llewellyn HR. Malignant lympho-epithelial lesion of the salivary gland: a case report and review of the literature. Australas Radiol 1993; 37: 288–91.
- 18
Albeck H, Bentzen J, Ockelmann HH, Nielsen NH, Bretlau P, Hansen HS.
Familial clusters of nasopharyngeal carcinoma and salivary gland carcinomas in Greenland natives.
Cancer
1993;
72:
196–200.
10.1002/1097-0142(19930701)72:1<196::AID-CNCR2820720135>3.0.CO;2-D CAS PubMed Web of Science® Google Scholar
- 19 Tsang WYW, Kuo TT, Chan J. Lymphoepithelial carcinoma. In: L Barnes, JW Everson, P Reichart, D Sidransky, eds. WHO classification of tumors. Pathology and genetics of head and neck tumors. Lyon: IARC Press, 2005. 251– 2.
- 20 Frisch M, Biggar RJ, Engels EA, Goedert JJ. Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001; 285: 1736–45.
- 21 Melbye M, Cote TR, West D, Kessler L, Biggar RJ. Nasopharyngeal carcinoma: an EBV-associated tumour not significantly influenced by HIV-induced immunosuppression. The AIDS/Cancer Working Group. Br J Cancer 1996; 73: 995–7.
- 22 Mbulaiteye SM, Katabira ET, Wabinga H, Parkin DM, Virgo P, Ochai R, Workneh M, Coutinho A, Engels EA. Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer 2006; 118: 985–90.
- 23 Serraino D, Boschini A, Carrieri P, Pradier C, Dorrucci M, Dal Maso L, Ballarini P, Pezzotti P, Smacchia C, Pesce A, Ippolito G, Franceschi S, et al. Cancer risk among men with, or at risk of HIV infection in southern Europe. AIDS 2000; 14: 553–9.
- 24 Newnham A, Harris J, Evans HS, Evans BG, Moller H. The risk of cancer in HIV-infected people in southeast England: a cohort study. Br J Cancer 2005; 92: 194– 200.
- 25 Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin LH, Parkin DM, Whelan S. International classification of diseases oncology, 3rd edn. Geneva: World Health Organization, 2000.
- 26 Saemundsen AK, Albeck H, Hansen JP, Nielsen NH, Anvret M, Henle W, Henle G, Thomsen KA, Kristensen HK, Klein G. Epstein-Barr virus in nasopharyngeal and salivary gland carcinomas of Greenland Eskimos. Br J Cancer 1982; 46: 721–8.
- 27 Hsu YC, Lu HF, Huang CC, Hsu RF, Su CY. Malignant lymphoepithelial lesions of the salivary gland. Otolaryngol Head Neck Surg 2006; 134: 661–6.
- 28 Wang CP, Chang YL, Ko JY, Lou PJ, Yeh CF, Sheen TS. Lymphoepithelial carcinoma versus large cell undifferentiated carcinoma of the major salivary glands. Cancer 2004; 101: 2020–7.
- 29 Wu LY, Cheng J, Lu Y, Zhou ZY, Saku T. Epstein-Barr virus infection in lymphoepithelial carcinoma of salivary glands in Sichuan Chinese. Sichuan Da Xue Xue Bao Yi Xue Ban 2004; 35: 506–7.
- 30 Hamilton-Dutoit SJ, Therkildsen MH, Neilsen NH, Jensen H, Hansen JP, Pallesen G. Undifferentiated carcinoma of the salivary gland in Greenlandic Eskimos: demonstration of Epstein-Barr virus DNA by in situ nucleic acid hybridization. Hum Pathol 1991; 22: 811–15.
- 31
Nagao T, Ishida Y, Sugano I, Tajima Y, Matsuzaki O, Hino T, Konno A, Kondo Y, Nagao K.
Epstein-Barr virus-associated undifferentiated carcinoma with lymphoid stroma of the salivary gland in Japanese patients. Comparison with benign lymphoepithelial lesion.
Cancer
1996;
78:
695–703.
10.1002/(SICI)1097-0142(19960815)78:4<695::AID-CNCR1>3.0.CO;2-E CAS PubMed Web of Science® Google Scholar
- 32 Herbst H, Niedobitek G. Sporadic EBV-associated lymphoepithelial salivary gland carcinoma with EBV-positive low-grade myoepithelial component. Virchows Arch 2006; 448: 648–54.
- 33 Saqui-Salces M, Martinez-Benitez B, Gamboa-Dominguez A. EBV+ lymphoepithelial carcinoma of the parotid gland in Mexican Mestizo patients with chronic autoimmune diseases. Pathol Oncol Res 2006; 12: 41–5.
- 34 Bialas M, Sinczak A, Choinska-Stefanska A, Zygulska A. EBV-positive lymphoepithelial carcinoma of salivary gland in a woman of a non-endemic area—a case report. Pol J Pathol 2002; 53: 235–8.
- 35
Pollock AM, Toner M, McMenamin M, Walker J, Timon CI.
Absence of Epstein-Barr virus encoded RNA and latent membrane protein (LMP1) in salivary gland neoplasms.
J Laryngol Otol
1999;
113:
906–8.
10.1017/S0022215100145542 Google Scholar
- 36 Gallo O, Santucci M, Calzolari A, Storchi OF. Epstein-Barr virus (EBV) infection and undifferentiated carcinoma of the parotid gland in Caucasian patients. Acta Otolaryngol 1994; 114: 572–5.
- 37 Chan JK, Yip TT, Tsang WY, Poon YF, Wong CS, Ma VW. Specific association of Epstein-Barr virus with lymphoepithelial carcinoma among tumors and tumorlike lesions of the salivary gland. Arch Pathol Lab Med 1994; 118: 994–7.
- 38 Jayaram G, Peh SC. Lymphoepithelial carcinoma of salivary gland—cytologic, histologic, immunocytochemical, and in situ hybridization features in a case. Diagn Cytopathol 2000; 22: 400–2.
- 39 Kotsianti A, Costopoulos J, Morgello S, Papadimitriou C. Undifferentiated carcinoma of the parotid gland in a white patient: detection of Epstein-Barr virus by in situ hybridization. Hum Pathol 1996; 27: 87–90.
- 40 Kuo T, Hsueh C. Lymphoepithelioma-like salivary gland carcinoma in Taiwan: a clinicopathological study of nine cases demonstrating a strong association with Epstein-Barr virus. Histopathology 1997; 31: 75–82.
- 41 Leung SY, Chung LP, Yuen ST, Ho CM, Wong MP, Chan SY. Lymphoepithelial carcinoma of the salivary gland: in situ detection of Epstein-Barr virus. J Clin Pathol 1995; 48: 1022–7.
- 42
Mourad WA, Kfoury HK, Ali MA.
B- and T-Lymphocyte distribution in benign and malignant lymphoepithelial lesions of the parotid gland: correlation with Epstein-Barr virus expression and a proposed mechanism of malignant transformation.
Ann Saudi Med
1997;
17:
4–9.
10.5144/0256-4947.1997.4 Google Scholar
- 43
Sheen TS, Tsai CC, Ko JY, Chang YL, Hsu MM.
Undifferentiated carcinoma of the major salivary glands.
Cancer
1997;
80:
357–63.
10.1002/(SICI)1097-0142(19970801)80:3<357::AID-CNCR2>3.0.CO;2-P CAS PubMed Web of Science® Google Scholar
- 44 Huang DP, Ng HK, Ho YH, Chan KM. Epstein-Barr virus (EBV)-associated undifferentiated carcinoma of the parotid gland. Histopathology 1988; 13: 509–17.
- 45 Jen KY, Cheng J, Li J, Wu L, Li Y, Yu S, Lin H, Chen Z, Gurtsevitch V, Saku T. Mutational events in LMP1 gene of Epstein-Barr virus in salivary gland lymphoepithelial carcinomas. Int J Cancer 2003; 105: 654–60.
- 46 Jen KY, Higuchi M, Cheng J, Li J, Wu LY, Li YF, Lin HL, Chen Z, Gurtsevitch V, Fujii M, Saku T. Nucleotide sequences and functions of the Epstein-Barr virus latent membrane protein 1 genes isolated from salivary gland lymphoepithelial carcinomas. Virus Genes 2005; 30: 223–35.
- 47 Lanier AP, Clift SR, Bornkamm G, Henle W, Goepfert H, Raab-Traub N. Epstein-Barr virus and malignant lymphoepithelial lesions of the salivary gland. Arctic Med Res 1991; 50: 55–61.
- 48 Lin H, Rao H, Saku. The significance of detecting EB virus and its products in benign and malignant lymphoepithelial lesions of the salivary glands. Zhonghua Bing Li Xue Za Zhi 1997; 26: 225–8.
- 49 Saku T, Cheng J, Jen KY, Tokunaga M, Li J, Zhang W, Liu A, Wu L, Lu Y, Zhou Z, Li Y, Li R, et al. Epstein-Barr virus infected lymphoepithelial carcinomas of the salivary gland in the Russia-Asia area: a clinicopathologic study of 160 cases. Arkh Patol 2003; 65: 35–9.
- 50 Lu SY, Huang CC, Hsiung CY, Eng HL, Huang HY. Primary lymphoepithelioma-like carcinoma of minor salivary gland: a case report with immunohistochemical and in situ hybridization studies. Head Neck 2006; 28: 182–6.
- 51 Vargas PA, Mauad T, Bohm GM, Saldiva PH, Almeida OP. Parotid gland involvement in advanced AIDS. Oral Dis 2003; 9: 55–61.
- 52 Hogg RP, Ayshford C, Watkinson JC. Parotid duct carcinoma arising in bilateral chronic sialadenitis. J Laryngol Otol 1999; 113: 686–8.
- 53
James PD, Ellis IO.
Malignant epithelial tumours associated with autoimmune sialadenitis.
J Clin Pathol
1986;
39:
497–502.
10.1136/jcp.39.5.497 Google Scholar
- 54 Tzioufas AG, Voulgarelis M. Update on Sjogren's syndrome autoimmune epithelitis: from classification to increased neoplasias. Best Pract Res Clin Rheumatol 2007; 21: 989–1010.
- 55 Baez A. Genetic and environmental factors in head and neck cancer genesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2008; 26: 174–200.
- 56 Ragin CC, Modugno F, Gollin SM. The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus. J Dent Res 2007; 86: 104–14.
- 57 Gillison ML, Shah KV. Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Curr Opin Oncol 2001; 13: 183–8.
- 58 Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709–20.
- 59 Lopez-Lizarraga E, Sanchez-Corona J, Montoya-Fuentes H, Bravo-Cuellar A, Campollo-Rivas O, Lopez-Demerutis E, Morgan-Villela G, Arcaute-Velazquez F, Monreal-Martinez JA, Troyo R. Human papillomavirus in tonsillar and nasopharyngeal carcinoma: isolation of HPV subtype 31. Ear Nose Throat J 2000; 79: 942–4.
- 60
Punwaney R, Brandwein MS, Zhang DY, Urken ML, Cheng R, Park CS, Li HB, Li X.
Human papillomavirus may be common within nasopharyngeal carcinoma of Caucasian Americans: investigation of Epstein-Barr virus and human papillomavirus in eastern and western nasopharyngeal carcinoma using ligation-dependent polymerase chain reaction.
Head Neck
1999;
21:
21–9.
10.1002/(SICI)1097-0347(199901)21:1<21::AID-HED3>3.0.CO;2-Z CAS PubMed Web of Science® Google Scholar
- 61 Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM, Biggar RJ. Trends in cancer risk among people with AIDS in the United States 1980–2002. AIDS 2006; 20: 1645–54.